Cost-effectiveness of influenza vaccination in high-risk children in Argentina

被引:30
|
作者
Dayan, GH
Nguyen, VH
Debbag, R
Gómez, R
Wood, SC
机构
[1] Fdn Ctr Estudios Infectol, Buenos Aires, DF, Argentina
[2] Aventis Pasteur, Buenos Aires, DF, Argentina
[3] Biogen Europe, Paris, France
关键词
influenza; vaccination; cost-effectiveness;
D O I
10.1016/S0264-410X(01)00160-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: our study aimed to evaluate the cost-effectiveness of influenza vaccination in high-risk children in Argentina. Methods: a decision analysis model was performed, using data from published and unpublished sources. to compare two strategies - to vaccinate or not to vaccinate. We simulated the expected consequences of vaccination on direct medical costs, related to disease management and indirect costs, related to lost parental working days (absenteeism). Results: Using base-case assumptions vaccination of high-risk children aged 6 months to 15 years old, in Argentina (estimated cohort of 1184748) would prevent 207331 cases of influenza, resulting in a reduction of 58052 days of hospitalization and 207331 outpatient visits. Vaccination would lead to net savings of US$ 11894870 per vaccinated cohort (US$ 10.04 per vaccinated child). Conclusion: our economic analysis shows that in Argentina, routine vaccination of high-risk children against influenza would be cost saving for society. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:4204 / 4213
页数:10
相关论文
共 50 条
  • [1] Cost-effectiveness of routine annual influenza vaccination by age and risk status
    DeLuca, Ellen Kim
    Gebremariam, Acham
    Rose, Angela
    Biggerstaff, Matthew
    Meltzer, Martin I.
    Prosser, Lisa A.
    VACCINE, 2023, 41 (29) : 4239 - 4248
  • [2] Cost-effectiveness of influenza vaccination of healthy children
    Salo, Heini
    Kilpi, Terhi
    Sintonen, Harri
    Linna, Miika
    Peltola, Ville
    Heikkinen, Terho
    VACCINE, 2006, 24 (23) : 4934 - 4941
  • [3] Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands
    de Boer, Pieter T.
    Nagy, Lisa
    Dolk, Franklin C. K.
    Wilschut, Jan C.
    Pitman, Richard
    Postma, Maarten J.
    VALUE IN HEALTH, 2021, 24 (01) : 19 - 31
  • [4] Cost-effectiveness of inactivated influenza vaccination in children with medical risk conditions in the Netherlands
    Naber, Steffie K.
    Bruijning-Verhagen, Patricia C. J. L.
    de Hoog, Marieke L. A.
    van Giessen, Anoukh
    VACCINE, 2020, 38 (17) : 3387 - 3396
  • [5] Cost-effectiveness of seasonal influenza vaccination of children in China: a modeling analysis
    Wang, Qiang
    Jin, Huajie
    Yang, Liuqing
    Jin, Hui
    Lin, Leesa
    INFECTIOUS DISEASES OF POVERTY, 2023, 12 (01)
  • [6] Cost-effectiveness of seasonal influenza vaccination of children in China: a modeling analysis
    Qiang Wang
    Huajie Jin
    Liuqing Yang
    Hui Jin
    Leesa Lin
    Infectious Diseases of Poverty, 12
  • [7] Cost-effectiveness analysis of influenza vaccination during pregnancy in Japan
    Hoshi, Shu-ling
    Shono, Aiko
    Seposo, Xerxes
    Okubo, Ichiro
    Kondo, Masahide
    VACCINE, 2020, 38 (46) : 7363 - 7371
  • [8] Influenza Vaccination Implementation in Sri Lanka: A Cost-Effectiveness Analysis
    Neighbors, Coralei E.
    Myers, Evan R.
    Weerasinghe, Nayani P.
    Wijayaratne, Gaya B.
    Bodinayake, Champica K.
    Nagahawatte, Ajith
    Tillekeratne, L. Gayani
    Woods, Christopher W.
    VACCINES, 2023, 11 (05)
  • [9] Health Benefits, Risks, and Cost-Effectiveness of Influenza Vaccination in Children
    Fleming, Douglas M.
    Elliot, Alex J.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2008, 27 (11) : S154 - S158
  • [10] Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany
    Oliver Damm
    Martin Eichner
    Markus Andreas Rose
    Markus Knuf
    Peter Wutzler
    Johannes Günter Liese
    Hagen Krüger
    Wolfgang Greiner
    The European Journal of Health Economics, 2015, 16 : 471 - 488